title: Towards proteome standards: the use of absolute quantitation in high-throughput biomarker discovery.
abstract: The use of proteomics to profile biological fluids and identify therein biomarkers for cancer and other diseases was initially received with considerable excitement. However, results have fallen short of the expectations. Traditionally, protein biomarkers have been identified by measurement of relative expression changes between case and control samples from which differentially expressed proteins are then considered to represent biomarker candidates. We argue that current individual proteomics-based biomarker discovery studies lack the statistical strength for the identification of high-confidence biomarkers. Instead, multi-group efforts are necessary to facilitate the generation of sufficient sample sizes. This is contingent on the ability to collate and cross-compare data from different studies, which will require the use of a common metric or standards. Though profound, the technical challenges for absolute protein quantification can be overcome. The use of matrix specific, shared standards for absolute quantitation presents an opportunity to facilitate the much needed, but currently impossible, comparisons of different studies. In addition to community-wide approaches to standardize pre-analytical biomarker research studies, it is also important to establish means to integrate experimental data from different studies in order to assess the usefulness of proposed biomarkers with sufficient statistical certainty.
authors.forename: Tzu-Chiao
authors.initials: TC
authors.lastname: Chao
authors.forename: Nicole
authors.initials: N
authors.lastname: Hansmeier
authors.forename: Rolf U
authors.initials: RU
authors.lastname: Halden
mesh_terms: D015415:Biomarkers / Q000032:analysis* / Q000378:metabolism; D006801:Humans; D020543:Proteome / Q000592:standards*; D040901:Proteomics / Q000379:methods / Q000592:standards*; D054928:Validation Studies as Topic
chemical_list: D015415:Biomarkers; D020543:Proteome
references.citation: Nat Biotechnol. 2006 Mar;24(3):333-8
references.pmid: 16525410
references.citation: BMC Med Genomics. 2008 Sep 15;1:41
references.pmid: 18793429
references.citation: J Proteome Res. 2007 Sep;6(9):3371-6
references.pmid: 17655344
references.citation: BMC Bioinformatics. 2003 Jun 9;4:24
references.pmid: 12795817
references.citation: N Engl J Med. 2004 May 27;350(22):2239-46
references.pmid: 15163773
references.citation: Clin Chem. 2008 Nov;54(11):1749-52
references.pmid: 18957555
references.citation: J Natl Cancer Inst. 2007 Jan 17;99(2):147-57
references.pmid: 17227998
references.citation: Biomark Insights. 2007 Feb 07;1:1-48
references.pmid: 19690635
references.citation: Urology. 2009 May;73(5 Suppl):S11-20
references.pmid: 19375622
references.citation: J Proteome Res. 2004 Mar-Apr;3(2):235-44
references.pmid: 15113099
references.citation: Bioinformatics. 2005 Aug 1;21(15):3301-7
references.pmid: 15905277
references.citation: Proteomics Clin Appl. 2007 Feb;1(2):148-56
references.pmid: 21136664
references.citation: Proteomics Clin Appl. 2008 Oct 1;2(10-11):1386-1402
references.pmid: 20976028
references.citation: Mol Cell Proteomics. 2007 Dec;6(12):2212-29
references.pmid: 17939991
references.citation: Cancer J. 2001 Jan-Feb;7(1):69-78
references.pmid: 11269650
references.citation: Mol Cell Proteomics. 2009 May;8(5):883-6
references.pmid: 19131327
references.citation: Anal Biochem. 2007 Mar 1;362(1):44-54
references.pmid: 17241609
references.citation: J Chromatogr B Biomed Sci Appl. 1999 Feb 5;722(1-2):191-202
references.pmid: 10068141
references.citation: Proteomics. 2001 Oct;1(10):1264-70
references.pmid: 11721637
references.citation: Mol Cell Proteomics. 2004 Apr;3(4):345-54
references.pmid: 14749446
references.citation: Bioinformatics. 2005 Jan 15;21(2):171-8
references.pmid: 15308542
references.citation: Bioinformatics. 2004 Mar 22;20(5):777-85
references.pmid: 14751995
references.citation: Cancer. 1994 Sep 1;74(5):1615-20
references.pmid: 7520352
references.citation: Nucleic Acids Res. 2009 Jan;37(Database issue):D907-12
references.pmid: 18978022
references.citation: Proteomics. 2009 Feb;9(4):861-81
references.pmid: 19212957
references.citation: Mol Cell Proteomics. 2007 Aug;6(8):1416-27
references.pmid: 17510050
references.citation: Mol Cell Proteomics. 2007 Sep;6(9):1666-7
references.pmid: 17766694
references.citation: Proteomics. 2001 Oct;1(10):1205-15
references.pmid: 11721633
references.citation: Nat Biotechnol. 2006 Aug;24(8):971-83
references.pmid: 16900146
references.citation: J Natl Cancer Inst. 2005 Feb 16;97(4):315-9
references.pmid: 15713968
references.citation: Toxicol Lett. 2001 Mar 31;120(1-3):379-84
references.pmid: 11323197
references.citation: Proteomics. 2005 Aug;5(13):3262-77
references.pmid: 16052621
references.citation: Nat Biotechnol. 2008 Aug;26(8):860-1
references.pmid: 18688232
references.citation: Nat Methods. 2009 Jun;6(6):423-30
references.pmid: 19448641
references.citation: Adv Genet. 2008;60:293-308
references.pmid: 18358325
references.citation: Nat Rev Cancer. 2006 Jul;6(7):565-71
references.pmid: 16794639
references.citation: Proteomics Clin Appl. 2009 Feb;3(2):173-84
references.pmid: 26238617
references.citation: J Cell Biochem. 2003 Aug 1;89(5):868-86
references.pmid: 12874822
references.citation: J Proteome Res. 2009 Feb;8(2):787-97
references.pmid: 19105742